1. Prognostic Value of TWIST1 and EZH2 Expression in Colon Cancer.
- Author
-
Abdel Raouf SM, Ibrahim TR, Abdelaziz LA, Farid MI, and Mohamed SY
- Subjects
- Adult, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Biomarkers, Tumor analysis, Carcinoma diagnosis, Carcinoma drug therapy, Carcinoma genetics, Colonic Neoplasms diagnosis, Colonic Neoplasms drug therapy, Colonic Neoplasms genetics, Disease-Free Survival, Egypt epidemiology, Enhancer of Zeste Homolog 2 Protein analysis, Epithelial-Mesenchymal Transition genetics, Female, Fluorouracil therapeutic use, Gene Expression Regulation, Neoplastic, Humans, Immunohistochemistry, Leucovorin therapeutic use, Lymphatic Metastasis genetics, Male, Middle Aged, Neoplasm Recurrence, Local genetics, Neoplasm Recurrence, Local pathology, Neoplasm Staging, Nuclear Proteins analysis, Organoplatinum Compounds therapeutic use, Prognosis, Prospective Studies, Risk Assessment methods, Twist-Related Protein 1 analysis, Young Adult, Biomarkers, Tumor metabolism, Carcinoma mortality, Colonic Neoplasms mortality, Enhancer of Zeste Homolog 2 Protein metabolism, Neoplasm Recurrence, Local epidemiology, Nuclear Proteins metabolism, Twist-Related Protein 1 metabolism
- Abstract
Background: Colorectal carcinoma (CRC) is the third most common human cancer. Twist, a basic helix-loop-helix (bHLH) transcription factor, is an epithelial-mesenchymal transition ((EMT) inducer that has been involved in carcinogenesis and chemoresistance. Also, the enhancer of Zeste homolologue2 (EZH2), a member of the polycomb group of genes, had been associated with poor prognosis in several malignancies., Objective: To evaluate the expression of Twist1 and EZH2 in colon carcinoma in Egyptian patients and its relation to clinicopathological parameters, prognosis, and survival., Methods: Twist1 and EZH2 expressions were evaluated immunohistochemically in 50 cases of colorectal tumors (12 colon adenomas and 38 colon carcinomas) and 20 samples from normal colonic mucosa., Results: The expression of Twist1 and EZH2 was significantly higher in colon adenoma and carcinoma than that in normal colonic mucosa (P < 0.05). Twist1 and EZH2 expressions were associated with decreased tumor differentiation, advanced stage, and lymph node metastasis. Twist1 and EZH2 expressions were significantly related to 3-year disease-free survival (P = 0.005 and 0.002 respectively) and 3-year overall survival (P = 0.045 and 0.039, respectively)., Conclusions: Twist1 and EZH2 may serve as prognostic predictors for colon carcinoma and may have a potential role as therapeutic targets in patients with colon carcinoma in the future.
- Published
- 2021
- Full Text
- View/download PDF